Real et al. found in estrogen receptor-negative metastatic breast cancer cell lines that activation of the STAT3-Bcl-2 pathway inhibited the autophagy and apoptosis of these cells, increased their survival benefits, and contributed to the development of drug resistance (Real et al., 2018). Here, STAT3 is linked to breast cancer.